Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07401225 · ClinicalTrials.gov registry record · NA

TMS for PTSD in Youth

A NA study, sponsored by The University of Texas Health Science Center at San Antonio.

Recruiting
Registry status
NA
Development phase
20
Enrollment target

NCT07401225: Recruiting NA study, sponsored by The University of Texas Health Science Center at San Antonio.

NCT07401225 is a NA study that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07401225, a NA study, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this study is to test whether transcranial magnetic stimulation, or TMS, is an acceptable and helpful treatment for ongoing symptoms of posttraumatic stress syndrome disorder (PTSD) in 12-20 year olds. Ongoing PTSD refers to symptoms that continue after completing trauma-focused psychotherapy. About 1 in 4 patients need additional help to overcome PTSD after completing psychotherapy. Currently, scientists do not know the best way to help adolescents with persistent PTSD, and this study will test TMS as a possible treatment, and hopefully lead to future studies including more people.

Primary Outcome

number of side effects reported per participant

Interventions

  • DEVICE MagPro R30 with robotic arm

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-05-09
Est. Completion 2027-08-31
Phase NA

What NCT07401225 shows while recruiting

NCT07401225 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which MagPro R30 with robotic arm is the first listed.

NCT07401225 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07401225 about?

NCT07401225 is a clinical study titled "TMS for PTSD in Youth". The purpose of this study is to test whether transcranial magnetic stimulation, or TMS, is an acceptable and helpful treatment for ongoing symptoms of posttraumatic stress syndrome disorder (PTSD) in 12-20 year olds. Ongoing PTSD refers to symptoms that continue after completing trauma-focused psych...

What is the current status of trial NCT07401225?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-05-09. Estimated completion is 2027-08-31.

What interventions are being tested in trial NCT07401225?

The interventions under investigation include: MagPro R30 with robotic arm (DEVICE).

Who is sponsoring clinical trial NCT07401225?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07401225's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07401225, the US trial registry maintained by the National Library of Medicine. NCT07401225 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.